株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

セルベースアッセイの世界市場 2024年までの予測:製品 (試薬、マイクロプレート、細胞株、アッセイキット、機器、サービス)・用途・エンドユーザー・地域別

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

発行 MarketsandMarkets 商品コード 301568
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
セルベースアッセイの世界市場 2024年までの予測:製品 (試薬、マイクロプレート、細胞株、アッセイキット、機器、サービス)・用途・エンドユーザー・地域別 Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
出版日: 2019年04月01日 ページ情報: 英文 133 Pages
概要

世界のセルベースアッセイ市場は、2019年には139億米ドル、2024年には189億米ドルと、6.3%のCAGR (複合年間成長率) で成長する見通しです。研究資金の増加や創薬活動の活発化などが、市場成長の主な要因として挙げられています。用途別では基礎研究向け需要が最大のシェアを占めており、また地域別ではアジア太平洋地域諸国が今後急速に成長する見込みです。

当レポートでは、世界のセルベースアッセイの市場について調査し、製品/サービス・用途・エンドユーザー・地域別の市場動向、市場規模と成長率の推移と予測、市場成長の促進・阻害要因ならびに市場機会の分析、競合環境、主要企業のプロファイルなど、体系的な情報を提供しています。

301568_4.1 CELL-BASED ASSAYS MARKET OVERVIEW_FIGURE 10

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • セルベースアッセイに対する選好の拡大
      • 研究資金の増額
      • 創薬活動の増加
    • 抑制要因
      • 検査機器のコストの高さと、試薬利用に対する制限
    • 市場機会
      • アジア諸国の急成長
      • がん研究における最新型のセルベースアッセイの活用

第6章 セルベースアッセイ市場:製品・サービス別

  • イントロダクション
  • 消耗品
    • 試薬
    • アッセイキット
      • レポーター遺伝子アッセイ
      • セカンドメッセンジャーアッセイ
      • 細胞増殖アッセイ
      • 細胞死アッセイ
      • その他
    • プローブ・ラベル
    • マイクロプレート
    • 細胞株
      • 不死化細胞株
      • 初代細胞株
      • 幹細胞株
    • その他
  • 機器
  • サービス

第7章 セルベースアッセイ市場:用途別

  • イントロダクション
  • 創薬
    • 毒性研究
    • 薬物動態研究
    • 薬力学的研究
  • 基礎研究
  • その他

第8章 セルベースアッセイ市場:エンドユーザー別

  • イントロダクション
  • 製薬企業・バイオテクノロジー企業
  • 教育機関・政府機関
  • CRO (医薬品開発業務受託機関)

第9章 セルベースアッセイ市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
  • 欧州 (英国、ドイツ、フランスなど)
  • アジア太平洋地域 (中国、日本、インドなど)
  • 他の国々 (RoW)

第10章 競争環境

  • 概要
  • 市場ランキング分析
    • セルベースアッセイの市場ランキング:主要企業の場合
  • 主要戦略 (過去4年間分)
    • 製品販売
    • 事業拡張
    • 事業協力
    • 企業買収
  • 企業戦略の方向性:マッピング
    • 先駆的企業
    • 革新的企業
    • 活動的企業
    • 新規企業
  • 企業戦略の方向性:スタートアップ企業の場合
    • 進歩的企業
    • 新規参入企業
    • 追従的企業
    • 活動的企業

第11章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • DANAHER CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • GE HEALTHCARE
  • MERCK KGAA
  • LONZA GROUP LTD.
  • PERKINELMER, INC.
  • CHARLES RIVER LABORATORIES, INC.
  • CELL SIGNALING TECHNOLOGY, INC.
  • PROMEGA CORPORATION
  • CISBIO
  • CELL BIOLABS, INC.

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: CELL-BASED CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: CELL-BASED CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: CELL-BASED REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: CELL-BASED ASSAY KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: CELL-BASED ASSAY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: REPORTER GENE ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: SECOND MESSENGER ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: CELL GROWTH ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: CELL DEATH ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: OTHER ASSAY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CELL-BASED PROBES & LABELS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CELL-BASED MICROPLATES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: CELL LINES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 15: CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: IMMORTALIZED CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: PRIMARY CELL LINES MARKET FOR, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: STEM CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: OTHER CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: CELL-BASED INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 23: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 25: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 31: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: CELL-BASED ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 39: US: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 40: US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: US: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 42: CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 43: CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 45: EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERIVECS, 2017-2024 (USD MILLION)
  • TABLE 47: EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 48: EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 49: UK: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 50: UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: UK: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 53: GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 54: GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 56: FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 58: ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 59: ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 61: APAC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: APAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 63: APAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: APAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 66: CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 68: JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 69: JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 70: JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 73: INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 74: ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 75: ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 76: ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: ROW: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 78: ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 79: ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: CELL-BASED ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: CELL-BASED ASSAYS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
  • FIGURE 11: DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN 2018
  • FIGURE 12: COUNTRIES IN APAC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 14: CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: DRUG DISCOVERY APPLICATIONS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO BE THE LARGEST END USERS OF CELL-BASED ASSAYS DURING THE FORECAST PERIOD
  • FIGURE 17: NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET
  • FIGURE 18: NORTH AMERICA: CELL-BASED ASSAY MARKET SNAPSHOT
  • FIGURE 19: APAC: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS IN THE CELL-BASED ASSAYS MARKET FROM 2015 TO 2019
  • FIGURE 21: MNM DIVE-VENDOR COMPARISON MATRIX: CELL-BASED ASSAYS MARKET
  • FIGURE 22: MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL-BASED ASSAYS MARKET
  • FIGURE 23: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 24: DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 25: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 26: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 27: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 28: LONZA GROUP LTD.: COMPANY SNAPSHOT (2017)
  • FIGURE 29: PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 30: CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2017)
目次
Product Code: BT 2486

"Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024"

The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.

"Services exhibited the highest CAGR over the forecast period."

By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.

"Basic research held the significant share in the cell-based assays market in 2019"

On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.

"Asia Pacific exhibited the highest CAGR over the forecast period"

North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

Some of the major players in this market include: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).

Research Coverage:

This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key Data from Secondary Sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CELL-BASED ASSAYS: MARKET OVERVIEW
  • 4.2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing preference for cell-based assays
      • 5.2.1.2 Growing research funding
      • 5.2.1.3 Growth in the number of drug discovery activities
    • 5.2.2 RESTRAINT
      • 5.2.2.1 High cost of instruments and restrictions on reagent use
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High-growth Asian countries
      • 5.2.3.2 Application of novel cell-based assays in cancer research

6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 REAGENTS
      • 6.2.1.1 Reagents have widespread usage in life sciences due to their application in immunology research, disease research, and cancer diagnostics
    • 6.2.2 ASSAY KITS
      • 6.2.2.1 Reporter gene assays
        • 6.2.2.1.1 Reporter gene assays can be used with limited resources for the establishment of HTS platforms, presenting opportunities for small laboratories with limited resources
      • 6.2.2.2 Second messenger assays
        • 6.2.2.2.1 Second messenger assays allow the detection and characterization of all compound classes-a key driver for market growth
      • 6.2.2.3 Cell growth assays
        • 6.2.2.3.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
      • 6.2.2.4 Cell death assays
        • 6.2.2.4.1 Cell death quantification is essential in drug development to identify the manner in which potential drugs could inhibit or enhance molecular targets-a key factor propelling market demand
      • 6.2.2.5 Other assay kits
    • 6.2.3 PROBES & LABELS
      • 6.2.3.1 Effective labeling of cells helps in studying cellular events in a spatial and temporal context-a key factor driving the demand for probes and labels
    • 6.2.4 MICROPLATES
      • 6.2.4.1 Increasing demand for cell-based assays in drug discovery, basic research, and preclinical safety studies is encouraging the consumption of microplates
    • 6.2.5 CELL LINES
      • 6.2.5.1 Immortalized cell lines
        • 6.2.5.1.1 Advantages of immortalized cell lines creating a demand for these cell lines over primary and stem cell lines
      • 6.2.5.2 Primary cell lines
        • 6.2.5.2.1 Primary cell lines are more sensitive as compared to immortalized cell lines-a key factor limiting market growth
      • 6.2.5.3 Stem cell lines
        • 6.2.5.3.1 Stem cell lines are alternative methodologies to address the cellularity issues that involve the directed differentiation of embryonic stem (ES) cells or induced pluripotent stem cells (iPS)
    • 6.2.6 OTHER CONSUMABLES
  • 6.3 INSTRUMENTS
    • 6.3.1 BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET
  • 6.4 SERVICES

7 CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 DRUG DISCOVERY
    • 7.2.1 TOXICITY STUDIES
      • 7.2.1.1 Increasing adoption of high-content screening for evaluating cytotoxicity is a factor stimulating the use of cell-based assays for toxicity studies
    • 7.2.2 PHARMACOKINETIC STUDIES
      • 7.2.2.1 Demand for ADME studies to rise due to the growing need for improved clinical success-a major factor driving growth
    • 7.2.3 PHARMACODYNAMIC STUDIES
      • 7.2.3.1 Increasing number of pharmacodynamics studies globally to drive growth in the cell-based assays market
  • 7.3 BASIC RESEARCH
    • 7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
  • 7.4 OTHER APPLICATIONS

8 CELL-BASED ASSAYS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES
  • 8.3 ACADEMIC & GOVERNMENT INSTITUTES
    • 8.3.1 INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
  • 8.4 CONTRACT RESEARCH ORGANIZATIONS
    • 8.4.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS

9 CELL-BASED ASSAYS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 UK
    • 9.3.2 GERMANY
    • 9.3.3 FRANCE
    • 9.3.4 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET RANKING ANALYSIS, 2017
    • 10.2.1 CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017
  • 10.3 KEY STRATEGIES
    • 10.3.1 PRODUCT LAUNCHES, 2015-2018
    • 10.3.2 EXPANSIONS, 2015-2018
    • 10.3.3 COLLABORATIONS, 2015-2018:
    • 10.3.4 ACQUISITIONS, 2015-2018
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2017)
  • 10.5 VISIONARY LEADERS
  • 10.6 INNOVATORS
    • 10.6.1 DYNAMIC DIFFERENTIATORS
    • 10.6.2 EMERGING COMPANIES
  • 10.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 STARTING BLOCKS
    • 10.7.3 RESPONSIVE COMPANIES
    • 10.7.4 DYNAMIC COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 THERMO FISHER SCIENTIFIC INC.
  • 11.2 DANAHER CORPORATION
  • 11.3 BECTON, DICKINSON AND COMPANY
  • 11.4 GE HEALTHCARE
  • 11.5 MERCK KGAA
  • 11.6 LONZA GROUP LTD.
  • 11.7 PERKINELMER, INC.
  • 11.8 CHARLES RIVER LABORATORIES, INC.
  • 11.9 CELL SIGNALING TECHNOLOGY, INC.
  • 11.10 PROMEGA CORPORATION
  • 11.11 CISBIO
  • 11.12 CELL BIOLABS, INC.

Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS OF INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS
Back to Top